Jasjot Singh has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech promoters Jasjot Singh and Parmjeet Kaur have acquired a total of 1,21,12,174 equity shares (7.03% of the company's share capital) from promoter-group entity Healthy Biosciences Limited via an off-market inter-se transfer at Rs. 4.20 per share. As a result, Jasjot Singh's holding rose from 11.01% (1.89 crore shares) to 16.81% (2.89 crore shares), while Parmjeet Kaur's holding increased from 3.30% (56.78 lakh shares) to 4.52% (77.90 lakh shares). Healthy Biosciences Limited has consequently been reduced to a zero holding. The transaction is exempt from an open offer under Regulation 10(1)(a)(ii) since it is an internal promoter-group transfer, meaning the aggregate promoter shareholding remains unchanged.
This is purely a reshuffling within the promoter group and does not change the total promoter ownership in the company. It has no direct dilution or value transfer impact for retail shareholders, though it concentrates ownership in individual promoter names rather than the corporate entity Healthy Biosciences.